Arconic Inc. v. Novelis Inc.

• Decision Date: 15 December 2020
• Docket Number: CIVIL ACTION NO. 17-1434
• Parties: ARCONIC INC., Plaintiff, v. NOVELIS INC. and NOVELIS CORP, Defendants.
• Court: U.S. District Court — Western District of Pennsylvania

ARCONIC INC., Plaintiff, v. NOVELIS INC. and NOVELIS CORP, Defendants.

CIVIL ACTION NO. 17-1434

UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF PENNSYLVANIA

December 15, 2020

JUDGE JOY FLOWERS CONTI

OPINION

Now pending before the court is a motion by defendants ("Novelis") for leave to file a motion for partial summary judgment on Count XIII of its amended counterclaims and "on the issue of the lawfulness of Arconic's royalties more generally" as it relates to Count XI of its amended counterclaims (ECF No. 527). Plaintiff ("Arconic") filed a response in opposition (ECF No. 567). In the alternative, Arconic requested leave to file partial summary judgment motions of its own. Novelis filed a motion for leave to file a reply brief (ECF No. 575), which the court will deny as moot.

Procedural Background

This has been an arduous and contentious case. The original complaint and counterclaims were filed in 2017. In February 2019, Novelis filed amended counterclaims, alleging antitrust violations and patent misuse.

Fact discovery is not complete. Fact discovery was stayed on Arconic's trade secret and confidential information claims in October 2018 due to its failure to identify its trade secrets/confidential information with reasonable particularity, as required by numerous court orders. Fact discovery on Novelis' amended counterclaims is largely complete, but fact discovery on Novelis' original counterclaims is intertwined with the trade secret/confidential information discovery.

On February 25, 2019, the court ordered Arconic to show cause why summary judgment should not be granted on Arconic's trade secret and confidential information claims (counts I through VI of the second amended complaint). After lengthy proceedings before the special master, the court heard oral argument on November 16, 2020 and on December 9, 2020, issued an opinion and order granting summary judgment in favor of Novelis on the trade secret claims and allowing certain confidential information claims to proceed on the narrow basis set forth in R&R #33. The stay of discovery is now lifted and the remaining fact discovery will be swiftly completed. The parties will have a discrete period of time to complete expert discovery and the record will be complete.

Discussion

The case management order provides: "Parties may not file motions for summary judgment without first requesting a hearing and the court entering a scheduling order." (ECF No. 102 ¶ 8). Motions for partial summary judgment are generally disfavored because they are resolved by orders that cannot be appealed until final adjudication. As a result, they are only permitted if they benefit the parties and serve the interest of judicial economy. Right Way Nutrition, LLC v. Gen. Nutrition Corp., 421 F. Supp. 3d 78, 87 (W.D. Pa. 2019); see Excentus Corp. v. Giant Eagle, Inc., No. CV 13-178, 2014 WL 12596562, at *2 (W.D. Pa. Mar. 24, 2014) (Conti, J.) (serial summary judgment motions are disfavored by the court).

The motion Novelis seeks leave to file would involve only one counterclaim and a legal issue implicated in another counterclaim.¹ Novelis also seeks injunctive and declaratory relief(ECF No. 528 at 11). There has been one round of summary judgment briefing in this case already (initiated by the court), which took over...